Francesco Grillone

Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations: Differential Effectiveness by Risk Group?

Matteo Santoni, Sebastiano Buti, Zin Myint et al. · European Urology Oncology · 2023 · 77 citations · Full text

Medicine, Immunology, Oncology +14

Phase II study of temozolomide plus pegylated liposomal doxorubicin in the treatment of brain metastases from solid tumours

Michele Caraglia, Raffaele Addeo, Raffaele Costanzo et al. · Cancer Chemotherapy and Pharmacology · 2005 · 68 citations

Medicine, Oncology, Pharmacology +16

Polymorphic Variants in <i><scp>NR</scp>1I3</i> and <i><scp>UGT</scp>2B7</i> Predict Taxane Neurotoxicity and Have Prognostic Relevance in Patients With Breast Cancer: A Case‐Control Study

Mariamena Arbitrio, Francesca Scionti, Emanuela Altomare et al. · Clinical Pharmacology & Therapeutics · 2019 · 34 citations

Medicine, Oncology, Pharmacology +17

Impact of Previous Nephrectomy on Clinical Outcome of Metastatic Renal Carcinoma Treated With Immune-Oncology: A Real-World Study on Behalf of Meet-URO Group (MeetUro-7b)

Marco Stellato, Daniele Santini, Elena Verzoni et al. · Frontiers in Oncology · 2021 · 29 citations · Full text

Medicine, Oncology, Surgery +17

Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study

Ondřej Fiala, Sebastiano Buti, Hideki Takeshita et al. · Cancer Immunology Immunotherapy · 2023 · 26 citations · Full text

Medicine, Oncology, Pharmacology +12